LynxDx, a biotechnology startup, is committed to the health of our community during the COVID-19 pandemic. We have focused our diagnostic laboratory to provide testing at-scale, particularly for our most vulnerable and high-risk populations.
Your facility has a physician’s order that permits patient samples to be collected
A medical professional collects patient samples via nasal or oral swab
Samples are packaged in transport media and sent to our laboratory
Our CLIA-licensed lab processes the samples using RNA isolation and PCR
Results are reported back to your facility within 24 hours
CLIA-certified (high complexity)
24-hour turnaround time
Both nasopharyngeal and
Reimbursable by insurance
Can process hundreds
What is LynxDx?
LynxDx is a prostate cancer diagnostics lab based in Ann Arbor, Michigan. To assist in the global response to the COVID-19 pandemic, LynxDx has re-focused our clinical laboratory to offer diagnostic COVID-19 testing.
What COVID-19 test are you performing?
We are using the FDA-approved Thermo Fisher qPCR test.
Do you do onsite testing for COVID-19?
We are working now to tailor our operation to the needs of any clients. We have currently been focusing on setting up onsite testing at nursing facilities (i.e., sending someone from our team to do the swabbing / collection). We have the collection kits and can mail out with return labels if there is a collection infrastructure already in place elsewhere.
How long does it take to get results?
24-48 hours depending on when we receive the samples
What lab capacity can you allocate per week (tests per week)?
We can perform 6,000-10,000 tests per week.
What is the cost of the tests?
In most cases, COVID-19 testing is reimbursable by insurance providers. The cash pay amount is $154.